Neurotoxicity
Information Page |
NINDS is part of the
National Institutes of
Health
Table of Contents (click to jump to sections)
What is Neurotoxicity?
Is there any treatment?
What is the prognosis?
What research is being done?
Organizations
What is Neurotoxicity?
Neurotoxicity occurs when the exposure to natural or manmade toxic substances (neurotoxicants) alters the normal activity
of the nervous system. This can eventually disrupt or even kill neurons, key cells that transmit and process signals in the
brain and other parts of the nervous system. Neurotoxicity can result from exposure to substances used in chemotherapy, radiation
treatment, drug therapies, and organ transplants, as well as exposure to heavy metals such as lead and mercury, certain foods
and food additives, pesticides, industrial and/or cleaning solvents, cosmetics, and some naturally occurring substances. Symptoms
may appear immediately after exposure or be delayed. They may include limb weakness or numbness; loss of memory, vision, and/or
intellect; headache; cognitive and behavioral problems; and sexual dysfunction. Individuals with certain disorders may be
especially vulnerable to neurotoxicants.
Is there any treatment?
What is the prognosis?
What research is being done?
Select this link to view a list of studies currently seeking patients.
National Institute of Environmental
Health Sciences (NIEHS) National Institutes of Health, DHHS 111 T.W. Alexander Drive Research Triangle Park, NC 27709 webcenter@niehs.nih.gov http://www.niehs.nih.gov Tel: 919-541-3345 |
Food and Drug Administration (FDA) U.S. Department of Health and Human Services 5600 Fishers Lane, CDER-HFD-240 Rockville, MD 20857 http://www.fda.gov Tel: 301-827-4573 888-INFO-FDA (463-6332) |
Prepared by:
Office of Communications and Public Liaison
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Bethesda, MD 20892
NINDS health-related material is provided for information purposes only and does not necessarily represent endorsement by or an official position of the National Institute of Neurological Disorders and Stroke or any other Federal agency. Advice on the treatment or care of an individual patient should be obtained through consultation with a physician who has examined that patient or is familiar with that patient's medical history.
All NINDS-prepared information is in the public domain and may be freely copied. Credit to the NINDS or the NIH is appreciated.
Last updated February 14, 2007